{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T05:07:47Z","timestamp":1722316067043},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T00:00:00Z","timestamp":1323820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00011-011-0407-5","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T09:21:04Z","timestamp":1323768064000},"page":"255-263","source":"Crossref","is-referenced-by-count":2,"title":["Leishmania (Viannia) shawi purified antigens confer protection against murine cutaneous leishmaniasis"],"prefix":"10.1007","volume":"61","author":[{"given":"Luiz Felipe Domingues","family":"Passero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Kely","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Luiza A. C.","family":"Bordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexis","family":"Bonfim-Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos Hikari","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Eduardo Pereira","family":"Corbett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcia Dalastra","family":"Laurenti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,14]]},"reference":[{"key":"407_CR1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","volume":"366","author":"HW Murray","year":"2005","unstructured":"Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet. 2005;366:1561\u20131567.","journal-title":"Lancet"},{"key":"407_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(06)64001-3","volume":"64","author":"AL Ba\u00f1uls","year":"2007","unstructured":"Ba\u00f1uls AL, Hide M, Prugnolle F. Leishmania and the leishmaniases: a parasite genetic update and advances in taxonomy, epidemiology and pathogenicity in humans. Adv Parasitol. 2007;64:1\u2013109.","journal-title":"Adv Parasitol"},{"key":"407_CR3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1590\/S0036-46652009000500003","volume":"51","author":"JA Lindoso","year":"2009","unstructured":"Lindoso JA, Lindoso AA. Neglected tropical diseases in Brazil. Rev Inst Med Trop Sao Paulo. 2009;51:247\u2013253.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"key":"407_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actatropica.2007.08.003","volume":"105","author":"VS Amato","year":"2008","unstructured":"Amato VS, Tuon FF, Bacha HA, Neto VA, Nicodemo AC. Mucosal leishmaniasis. Current scenario and prospects for treatment. Acta Trop. 2008;105:1\u20139.","journal-title":"Acta Trop"},{"key":"407_CR5","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-3024.2009.01116.x","volume":"31","author":"FT Silveira","year":"2009","unstructured":"Silveira FT, Lainson R, De Castro Gomes CM, Laurenti MD, Corbett CE. Immunopathogenic competences of Leishmania (V.) braziliensis and L. (L.) amazonensis in American cutaneous leishmaniasis. Parasite Immunol. 2009;31:423\u2013431.","journal-title":"Parasite Immunol"},{"key":"407_CR6","doi-asserted-by":"crossref","unstructured":"Prajeeth CK, Haeberlein S, Sebald H, Schleicher U, Bogdan C. Leishmania-infected macrophages are targets of NK cell-derived cytokines, but not of NK cell cytotoxicity. Infect Immun. 2011;79:2699\u20132708. doi: 10.1128\/IAI.00079-11 .","DOI":"10.1128\/IAI.00079-11"},{"key":"407_CR7","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1292\/jvms.70.589","volume":"70","author":"H Ota","year":"2008","unstructured":"Ota H, Takashima Y, Matsumoto Y, Hayashi Y, Matsumoto Y. Pretreatment of macrophages with the combination of IFN-gamma and IL-12 induces resistance to Leishmania major at the early phase of infection. J Vet Med Sci. 2008;70:589\u2013593.","journal-title":"J Vet Med Sci"},{"key":"407_CR8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-3083.2005.01681.x","volume":"62","author":"FC Aranha","year":"2005","unstructured":"Aranha FC, Ribeiro U Jr, Basse P, Corbett CE, Laurenti MD. Interleukin-2-activated natural killer cells may have a direct role in the control of Leishmania (Leishmania) amazonensis promastigote and macrophage infection. Scand J Immunol. 2005;62:334\u2013341.","journal-title":"Scand J Immunol"},{"key":"407_CR9","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.4049\/jimmunol.168.9.4628","volume":"168","author":"P Launois","year":"2002","unstructured":"Launois P, Gumy A, Himmelrich H, Locksley RM, R\u00f6cken M, Louis JA. Rapid IL-4 production by Leishmania homolog of mammalian RACK1-reactive CD4(+) T cells in resistant mice treated once with anti-IL-12 or -IFN-gamma antibodies at the onset of infection with Leishmania major instructs Th2 cell development, resulting in nonhealing lesions. J Immunol. 2002;168:4628\u20134635.","journal-title":"J Immunol"},{"key":"407_CR10","doi-asserted-by":"crossref","first-page":"4819","DOI":"10.4049\/jimmunol.164.9.4819","volume":"164","author":"H Himmelrich","year":"2000","unstructured":"Himmelrich H, Launois P, Maillard I, Biedermann T, Tacchini-Cottier F, Locksley RM, R\u00f6cken M, Louis JA. In BALB\/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease. J Immunol. 2000;164:4819\u20134825.","journal-title":"J Immunol"},{"key":"407_CR11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ijpara.2004.10.015","volume":"35","author":"D Strauss-Ayali","year":"2005","unstructured":"Strauss-Ayali D, Baneth G, Shor S, Okano F, Jaffe CL. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs. Int J Parasitol. 2005;35:63\u201373.","journal-title":"Int J Parasitol"},{"key":"407_CR12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.exppara.2010.05.008","volume":"126","author":"KA Jordan","year":"2010","unstructured":"Jordan KA, Hunter CA. Regulation of CD8+T cell responses to infection with parasitic protozoa. Exp Parasitol. 2010;126:318\u2013325.","journal-title":"Exp Parasitol"},{"key":"407_CR13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.parint.2009.12.010","volume":"59","author":"LFD Passero","year":"2010","unstructured":"Passero LFD, Marques C, Vale-Gato I, Corbett CE, Laurenti MD, Santos-Gomes G. Histopathology, humoral and cellular immune response in the murine model of Leishmania (Viannia) shawi. Parasitol Int. 2010;59:159\u2013165.","journal-title":"Parasitol Int"},{"key":"407_CR14","doi-asserted-by":"crossref","first-page":"e845","DOI":"10.1371\/journal.pntd.0000845","volume":"4","author":"M Nateghi Rostami","year":"2010","unstructured":"Nateghi Rostami M, Keshavarz H, Edalat R, Sarrafnejad A, Shahrestani T, Mahboudi F, Khamesipour A. CD8+\u00a0T cells as a source of IFN-\u03b3 production in human cutaneous leishmaniasis. PLoS Negl Trop Dis. 2010;4:e845.","journal-title":"PLoS Negl Trop Dis"},{"key":"407_CR15","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.vaccine.2007.11.044","volume":"26","author":"JH Ferreira","year":"2008","unstructured":"Ferreira JH, Gentil LG, Dias SS, Fedeli CE, Katz S, Barbi\u00e9ri CL. Immunization with the cysteine proteinase Ldccys1 gene from Leishmania (Leishmania) chagasi and the recombinant Ldccys1 protein elicits protective immune responses in a murine model of visceral leishmaniasis. Vaccine. 2008;26:677\u2013685.","journal-title":"Vaccine"},{"key":"407_CR16","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s00436-009-1614-7","volume":"105","author":"LF Passero","year":"2009","unstructured":"Passero LF, Sacomori JV, Tomokane TY, Corbett CE, da Silveira FT, Laurenti MD. Ex vivo and in vivo biological behavior of Leishmania (Viannia) shawi. Parasitol Res. 2009;105:1741\u20131747.","journal-title":"Parasitol Res"},{"key":"407_CR17","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.ijpara.2007.08.010","volume":"38","author":"N Wanasen","year":"2008","unstructured":"Wanasen N, Xin L, Soong L. Pathogenic role of B cells and antibodies in murine Leishmania amazonensis infection. Int J Parasitol. 2008;38:417\u2013419.","journal-title":"Int J Parasitol"},{"key":"407_CR18","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1590\/S0074-02762004000300001","volume":"99","author":"FT Silveira","year":"2004","unstructured":"Silveira FT, Lainson R, Corbett CE. Clinical and immunopathological spectrum of American cutaneous leishmaniasis with special reference to the disease in Amazonian Brazil: a review. Mem Inst Oswaldo Cruz. 2004;99:239\u2013251.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"407_CR19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/path.2403","volume":"216","author":"C Souza-Lemos","year":"2008","unstructured":"Souza-Lemos C, de-Campos SN, Teva A, C\u00f4rte-Real S, Fonseca EC, Porrozzi R, Grimaldi G Jr. Dynamics of immune granuloma formation in a Leishmania braziliensis-induced self-limiting cutaneous infection in the primate Macaca mulatta. J Pathol. 2008;216:375\u2013386.","journal-title":"J Pathol"},{"key":"407_CR20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1365-3024.2010.01256.x","volume":"33","author":"R Novoa","year":"2011","unstructured":"Novoa R, Bacellar O, Nascimento M, Cardoso TM, Ramasawmy R, Oliveira WN, Schriefer A, Carvalho EM. IL-17 and Regulatory Cytokines (IL-10 and IL-27) in L. braziliensis infection. Parasite Immunol. 2011;33:132\u2013136.","journal-title":"Parasite Immunol"},{"key":"407_CR21","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.micinf.2005.11.011","volume":"8","author":"ET Guimar\u00e3es","year":"2006","unstructured":"Guimar\u00e3es ET, Santos LA, Ribeiro dos Santos R, Teixeira MM, dos Santos WL, Soares MB. Role of interleukin-4 and prostaglandin E2 in Leishmania amazonensis infection of BALB\/c mice. Microbes Infect. 2006;8:1219\u20131226.","journal-title":"Microbes Infect"},{"key":"407_CR22","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0035-9203(03)80109-8","volume":"97","author":"PM Luca De","year":"2003","unstructured":"De Luca PM, Mayrink W, Santiago MA, Nogueira R, Concei\u00e7\u00e3o-Silva F, M\u00e9lo G, Mendon\u00e7a SC. Randomized, double-blind, placebo-controlled study on the immunogenicity of the leishmanin skin test. Trans R Soc Trop Med Hyg. 2003;97:709\u2013712.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"407_CR23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2249.2006.02995.x","volume":"143","author":"E Telino","year":"2006","unstructured":"Telino E, De Luca PM, Matos DC, Azeredo-Coutinho RB, Meirelles MN, Concei\u00e7\u00e3o-Silva F, Schubach A, Mendon\u00e7a SC. In vitro responses of human peripheral blood mononuclear cells to whole-cell, particulate and soluble extracts of Leishmania promastigotes. Clin Exp Immunol. 2006;143:338\u2013344.","journal-title":"Clin Exp Immunol"},{"key":"407_CR24","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.trstmh.2009.12.002","volume":"104","author":"AM Montalvo Alvarez","year":"2010","unstructured":"Montalvo Alvarez AM, Nodarse JF, Goodridge IM, Fidalgo LM, Marin M, Van Der Auwera G, Dujardin JC, Bernal ID, Muskus C. Differentiation of Leishmania (Viannia) panamensis and Leishmania (V.) guyanensis using BccI for hsp70 PCR-RFLP. Trans R Soc Trop Med Hyg. 2010;104:364\u2013367.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"407_CR25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1590\/S0074-02762005000600014","volume":"100","author":"JR Corr\u00eaa","year":"2005","unstructured":"Corr\u00eaa JR, Brazil RP, Soares MJ. Leishmania (Viannia) lainsoni (Kinetoplastida: Trypanosomatidae), a divergent Leishmania of the Viannia subgenus\u2014a mini review. Mem Inst Oswaldo Cruz. 2005;100:587\u2013592.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"407_CR26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1051\/parasite\/200209143","volume":"9","author":"FT Silveira","year":"2002","unstructured":"Silveira FT, Ishikawa EA, De Souza AA, Lainson R. An outbreak of cutaneous leishmaniasis among soldiers in Bel\u00e9m, Par\u00e1 State, Brazil, caused by Leishmania (Viannia) lindenbergi n. sp. A new leishmanial parasite of man in the Amazon region. Parasite. 2002;9:43\u201350.","journal-title":"Parasite"},{"key":"407_CR27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1051\/parasite\/1991666243","volume":"66","author":"JJ Shaw","year":"1991","unstructured":"Shaw JJ, Ishikawa EA, Lainson R, Braga RR, Silveira FT. Cutaneous leishmaniasis of man due to Leishmania (Viannia) shawi Lainson, de Souza, P\u00f3voa, Ishikawa & Silveira, in Par\u00e1 State, Brazil. Ann Parasitol Hum Comp. 1991;66:243\u2013246.","journal-title":"Ann Parasitol Hum Comp"},{"key":"407_CR28","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1111\/j.1365-3156.2009.02361.x","volume":"14","author":"ME Brito","year":"2009","unstructured":"Brito ME, Andrade MS, Mendon\u00e7a MG, Silva CJ, Almeida EL, Lima BS, F\u00e9lix SM, Abath FG, da Gra\u00e7a GC, Porrozzi R, Ishikawa EA, Shaw JJ, Cupolillo E, Brand\u00e3o-Filho SP. Species diversity of Leishmania (Viannia) parasites circulating in an endemic area for cutaneous leishmaniasis located in the Atlantic rainforest region of northeastern Brazil. Trop Med Int Health. 2009;14:1278\u20131286.","journal-title":"Trop Med Int Health"},{"key":"407_CR29","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1600-0463.2010.02679.x","volume":"118","author":"LFD Passero","year":"2010","unstructured":"Passero LFD, Bordon MLAC, Carvalho AK, Martins LM, Corbett CEP, Laurenti MD. Exacerbation of L. (V.) shawi infection after immunization with soluble antigen from amastigote forms. APMIS. 2010;118:973\u2013981.","journal-title":"APMIS"},{"key":"407_CR30","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.toxicon.2005.09.008","volume":"47","author":"MH Toyama","year":"2001","unstructured":"Toyama MH, Toyama DO, Passero LF, Laurenti MD, Corbett CE, Tomokane TY, Fonseca FV, Antunes E, Joazeiro PP, Beriam LO, Martins MA, Monteiro HS, Fonteles MC. Isolation of a new l-amino acid oxidase from Crotalus durissus cascavella venom. Toxicon. 2001;47:47\u201357.","journal-title":"Toxicon"},{"key":"407_CR31","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-3024.1985.tb00098.x","volume":"7","author":"RG Titus","year":"1985","unstructured":"Titus RG, Marchand M, Boon T, Louis JA. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 1985;7:545\u2013555.","journal-title":"Parasite Immunol"},{"key":"407_CR32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","volume":"89","author":"F Denizot","year":"1986","unstructured":"Denizot F, Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods. 1986;89:271\u2013277.","journal-title":"J Immunol Methods"},{"key":"407_CR33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0022-1759(86)90215-2","volume":"94","author":"D Gerlier","year":"1986","unstructured":"Gerlier D, Thomasset N. Use of MTT colorimetric assay to measure cell activation. J Immunol Methods. 1986;94:57\u201363.","journal-title":"J Immunol Methods"},{"key":"407_CR34","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0065-2776(08)60536-2","volume":"54","author":"RL Coffman","year":"1993","unstructured":"Coffman RL, Lebman DA, Rothman P. Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol. 1993;54:229\u2013270.","journal-title":"Adv Immunol"},{"key":"407_CR35","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.trstmh.2008.05.020","volume":"102","author":"FT Silveira","year":"2008","unstructured":"Silveira FT, Lainson R, Gomes CM, Laurenti MD, Corbett CE. Reviewing the role of the dendritic Langerhans cells in the immunopathogenesis of American cutaneous leishmaniasis. Trans R Soc Trop Med Hyg. 2008;102:1075\u20131080.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"407_CR36","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1126\/science.290.5495.1354","volume":"290","author":"VP Badovinac","year":"2000","unstructured":"Badovinac VP, Tvinnereim AR, Harty JT. Regulation of antigen-specific CD8+\u00a0T cell homeostasis by perforin and interferon-gamma. Science. 2000;290:1354\u20131358.","journal-title":"Science"},{"key":"407_CR37","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.4049\/jimmunol.175.9.5624","volume":"175","author":"JK Whitmire","year":"2005","unstructured":"Whitmire JK, Benning N, Whitton JL. Cutting edge: early IFN-gamma signaling directly enhances primary antiviral CD4+\u00a0T cell responses. J Immunol. 2005;175:5624\u20135628.","journal-title":"J Immunol"},{"key":"407_CR38","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1128\/IAI.69.3.1499-1507.2001","volume":"69","author":"S Bhattacharyya","year":"2001","unstructured":"Bhattacharyya S, Ghosh S, Jhonson PL, Bhattacharya SK, Majumdar S. Immunomodulatory role of interleukin-10 in visceral leishmaniasis: defective activation of protein kinase C-mediated signal transduction events. Infect Immun. 2001;69:1499\u20131507.","journal-title":"Infect Immun"},{"key":"407_CR39","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.4049\/jimmunol.169.6.3232","volume":"169","author":"A Aseffa","year":"2002","unstructured":"Aseffa A, Gumy A, Launois P, MacDonald HR, Louis JA, Tacchini-Cottier F. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB\/c mice are subject to the control of regulatory CD4\u00a0+\u00a0CD25\u00a0+\u00a0T cells. J Immunol. 2002;169:3232\u20133241.","journal-title":"J Immunol"},{"key":"407_CR40","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4049\/jimmunol.170.1.394","volume":"170","author":"D Xu","year":"2003","unstructured":"Xu D, Liu H, Komai-Koma M, Campbell C, McSharry C, Alexander J, Liew FY. CD4\u00a0+\u00a0CD25\u00a0+\u00a0regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J Immunol. 2003;170:394\u2013399.","journal-title":"J Immunol"},{"key":"407_CR41","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1172\/JCI116878","volume":"92","author":"BJ Holaday","year":"1993","unstructured":"Holaday BJ, Pompeu MM, Jeronimo S, Texeira MJ, Sousa Ade A, Vasconcelos AW, Pearson RD, Abrams JS, Locksley RM. Potential role for interleukin-10 in the immunosuppression associated with kala azar. J Clin Invest. 1993;92:2626\u20132632.","journal-title":"J Clin Invest"},{"key":"407_CR42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.exppara.2010.06.033","volume":"127","author":"PA Tabatabaee","year":"2011","unstructured":"Tabatabaee PA, Abolhassani M, Mahdavi M, Nahrevanian H, Azadmanesh K. Leishmania major: secreted antigens of Leishmania major promastigotes shift the immune response of the C57BL\/6 mice toward Th2 in vitro. Exp Parasitol. 2011;127:46\u201351.","journal-title":"Exp Parasitol"},{"key":"407_CR43","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1128\/IAI.00309-10","volume":"79","author":"VM Silva","year":"2011","unstructured":"Silva VM, Larangeira DF, Oliveira PR, Sampaio RB, Suzart P, Biointervention Student Group, Nihei JS, Teixeira MC, Mengel JO, dos-Santos WL, Pontes-de-Carvalho L. Enhancement of experimental cutaneous leishmaniasis by Leishmania molecules is dependent on interleukin-4, serine protease\/esterase activity, and parasite and host genetic backgrounds. Infect Immun. 2011;79:1236\u20131243.","journal-title":"Infect Immun"},{"key":"407_CR44","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1128\/CVI.00249-09","volume":"16","author":"EM Laabs","year":"2009","unstructured":"Laabs EM, Wu W, Mendez S. Vaccination with live Leishmania major and CpG DNA promotes interleukin-2 production by dermal dendritic cells and NK cell activation. Clin Vaccine Immunol. 2009;16:1601\u20131606.","journal-title":"Clin Vaccine Immunol"},{"key":"407_CR45","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.4049\/jimmunol.0901348","volume":"184","author":"AG Joyee","year":"2010","unstructured":"Joyee AG, Uzonna J, Yang X. Invariant NKT cells preferentially modulate the function of CD8 alpha+ dendritic cell subset in inducing type 1 immunity against infection. J Immunol. 2010;184:2095\u20132106.","journal-title":"J Immunol"},{"key":"407_CR46","doi-asserted-by":"crossref","first-page":"378","DOI":"10.4269\/ajtmh.2009.81.378","volume":"81","author":"LI Pereira","year":"2009","unstructured":"Pereira LI, Dorta ML, Pereira AJ, Bastos RP, Oliveira MA, Pinto SA, Galdino H Jr, Mayrink W, Barcelos W, Toledo VP, Lima GM, Ribeiro-Dias F. Increase of NK cells and proinflammatory monocytes are associated with the clinical improvement of diffuse cutaneous leishmaniasis after immunochemotherapy with BCG\/Leishmania antigens. Am J Trop Med Hyg. 2009;81:378\u2013383.","journal-title":"Am J Trop Med Hyg"},{"key":"407_CR47","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1128\/IAI.61.8.3459-3465.1993","volume":"61","author":"L Morris","year":"1993","unstructured":"Morris L, Troutt AB, McLeod KS, Kelso A, Handman E, Aebischer T. Interleukin-4 but not gamma interferon production correlates with the severity of murine cutaneous leishmaniasis. Infect Immun. 1993;61:3459\u20133465.","journal-title":"Infect Immun"},{"key":"407_CR48","doi-asserted-by":"crossref","first-page":"364","DOI":"10.4049\/jimmunol.165.1.364","volume":"165","author":"DE Jones","year":"2000","unstructured":"Jones DE, Buxbaum LU, Scott P. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection. J Immunol. 2000;165:364\u2013372.","journal-title":"J Immunol"},{"key":"407_CR49","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1590\/S0074-02762004000300009","volume":"99","author":"SM Souza-Neto de","year":"2004","unstructured":"de Souza-Neto SM, Carneiro CM, Vieira LQ, Afonso LC. Leishmania braziliensis: partial control of experimental infection by interleukin-12 p40 deficient mice. Mem Inst Oswaldo Cruz. 2004;99:289\u2013294.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"407_CR50","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1002\/1521-4141(200211)32:11<3206::AID-IMMU3206>3.0.CO;2-J","volume":"32","author":"LU Buxbaum","year":"2002","unstructured":"Buxbaum LU, Uzonna JE, Goldschmidt MH, Scott P. Control of New World cutaneous leishmaniasis is IL-12 independent but STAT4 dependent. Eur J Immunol. 2002;32:3206\u20133215.","journal-title":"Eur J Immunol"},{"key":"407_CR51","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","volume":"13","author":"B Oppmann","year":"2000","unstructured":"Oppmann B, Lesley R, Blom B, Timans JC, Xu Y, Hunte B, Vega F, Yu N, Wang J, Singh K, Zonin F, Vaisberg E, Churakova T, Liu M, Gorman D, Wagner J, Zurawski S, Liu Y, Abrams JS, Moore KW, Rennick D, de Waal-Malefyt R, Hannum C, Bazan JF, Kastelein RA. Novel p19 protein engages IL-12p40 to form a cytokine, IL- 23, with biological activities similar as well as distinct from IL-12. Immunity. 2000;13:715\u2013725.","journal-title":"Immunity"},{"key":"407_CR52","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","volume":"16","author":"S Pflanz","year":"2002","unstructured":"Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, Hibbert L, Churakova T, Travis M, Vaisberg E, Blumenschein WM, Mattson JD, Wagner JL, To W, Zurawski S, McClanahan TK, Gorman DM, Bazan JF, de Waal Malefyt R, Rennick D, Kastelein RA. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity. 2002;16:779\u2013790.","journal-title":"Immunity"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-011-0407-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00011-011-0407-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-011-0407-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T18:28:42Z","timestamp":1593368922000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00011-011-0407-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,14]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["407"],"URL":"https:\/\/doi.org\/10.1007\/s00011-011-0407-5","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"value":"1023-3830","type":"print"},{"value":"1420-908X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,14]]}}}